Skip to main content

and
  1. No Access

    Article

    Serum HE4 and CA125 as predictors of response and outcome during neoadjuvant chemotherapy of advanced high-grade serous ovarian cancer

    Human epididymis protein 4 (HE4) is a novel tumour marker in epithelial ovarian cancer (EOC). Data on its profile and predictive potential for subsequent outcome after neoadjuvant chemotherapy (NACT) are still...

    Tuulia Vallius, Johanna Hynninen, Annika Auranen, Olli Carpén in Tumor Biology (2014)